Anna Falanga
Anna Falanga publishes mostly in Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Myeloproliferative Neoplasms: Diagnosis and Treatment and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #106,202 of 7,710,434 ranked researchers
- Rank in Italy
- #2,076 of 242,206
- Works
- 537
- Citations
- 33k
- Citations per work
- 60.5
What does Anna Falanga research?
Anna Falanga's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences31458.4%
- Medicine31458.4%
- Everything else19235.7%
- Life Sciences325.9%
- 1Hematology17% of their works
- 2Internal Medicine16% of their works
- 3Cardiology and Cardiovascular Medicine11% of their works
- 4Genetics8% of their works
- 5Oncology6% of their works
- 6Molecular Biology6% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Acute Myeloid Leukemia Research
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Anna Falanga's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Pulmonary Embolism, Venous Thromboembolism, Hemostasis, Inflammation, Thrombosis and JAK2 Mutation.
- Heparin-Induced Thrombocytopenia
- AML
- Catheter-Related Infections
- Anticoagulant Therapy
- Immune Thrombocytopenic Purpura
- Protease-Activated Receptors
- JAK2 Mutation
- Inflammation
- Venous Thromboembolism
- Diagnosis
- Antithrombotic Therapy
- Pulmonary Embolism
- Hemostasis
- Thrombosis
- Myelofibrosis
- Thrombin
- Platelets
- Atrial Fibrillation
- Central Venous Catheterization
- Acute Myeloid Leukemia
- Vaccination
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antithrombotic Therapy3132 topics
- Diagnosis2652 topics
- Pulmonary Embolism2331 topic
- Venous Thromboembolism2331 topic
- Hemostasis1352 topics
- Inflammation1352 topics
- Thrombosis872 topics
- JAK2 Mutation801 topic
- Myelofibrosis801 topic
- Protease-Activated Receptors801 topic
- Thrombin801 topic
- Immune Thrombocytopenic Purpura551 topic
- Platelets551 topic
- Anticoagulant Therapy481 topic
- Atrial Fibrillation481 topic
- Catheter-Related Infections331 topic
- Central Venous Catheterization331 topic
- AML321 topic
- Acute Myeloid Leukemia321 topic
- Heparin-Induced Thrombocytopenia321 topic
- Vaccination321 topic
Where does Anna Falanga work?
Anna Falanga's main affiliation in the publication record is Ospedale Papa Giovanni XXIII, Italy.
How many publications and citations does Anna Falanga have?
OpenAlex counts 537 works and 32,512 citations for Anna Falanga, an h-index of 82, ranking #106,202 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna Falanga. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.